![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Compex's IF 3WAVE Interferential Device
FDA Clears Compex's IF 3WAVE Interferential Device
May 3, 2005
Compex Technologies, a company specializing in the design and manufacture of electrical muscle stimulation (EMS) products used for sports performance enhancement, rehabilitation and pain management, announced that its Rehabilicare division has received FDA clearance of its IF 3WAVE interferential device.
The device is designed specifically for pain management. Pain management physicians, orthopedic physicians and other physicians will prescribe the device to chronic pain patients. IF 3WAVE captures patient usage data, which can be downloaded from patients' homes and reported to their healthcare providers.
The IF 3WAVE is a PDA-sized device worn by the patient to manage pain throughout the day. The device combines multiple modalities that allow patients to treat pain, reduce edema and improve muscle rehabilitation. It offers easy-to-use preset programs and the ability to capture and transfer patient-compliance data. IF 3WAVE also offers patients and physicians the alternative of managing chronic pain without the use of prescription drugs.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct